skip to main content
Show Results with:

Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer

Gastric Cancer, Jul 2016, Vol.19(3), pp.927-938 [Peer Reviewed Journal]

No full-text

Searching Remote Databases, Please Wait